Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Marking Minute: Formulating Vinyl for Medical Applications with Beth Guinn

The medical and healthcare field is one that revolves around trust, and our guest plays a big part in that. Beth Guinn is the VP of Engineered Film Sales at Presco, and she joins host Tyler Kern to talk about how Presco formulates vinyl for various medical applications on this episode of The Marking…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

The medical and healthcare field is one that revolves around trust, and our guest plays a big part in that.

Beth Guinn is the VP of Engineered Film Sales at Presco, and she joins host Tyler Kern to talk about how Presco formulates vinyl for various medical applications on this episode of The Marking Minute.

Guinn wants the audience to know that Presco has the knowledge and resources to help customers in the medical and healthcare field qualify a vinyl film for their medical device.

Guinn explained that there are several devices in the hospital and medical field that are made out of vinyl. For instance, one is a compression device that prevents blood clots. Other devices with flexible vinyl include blood, urine, IV and ostomy product bags, inflatable bladders, and much more. Presco’s flexible vinyl film can be easily manipulated to directly impact the physical and safety requirements of the finished product.

Presco has the experience to create products that hold up to exact regulatory and performance standards. Guinn said that regulations are different in the U.S. than in Europe, and Presco also offers EVA as an alternative to PVC for regulatory requirements. Guinn said that Presco will help customers navigate these challenges to create a quality vinyl film.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Pharma M&A surges on a single day: KKR's $5.7B Integer deal, Curium's $8B Lantheus buy, and AstraZeneca's blocked megamerger signal a restructuring market

Three significant transactions occurred in the pharmaceutical and medtech sectors on August 3, highlighting a split M&A market. While mid-market buyouts such as KKR's acquisition of Integer Holdings and Curium's purchase of Lantheus proceeded, larger megamergers like AstraZeneca's faced obstacles. This suggests a trend towards restructuring within the industry.

  • 01KKR acquired Integer Holdings for $5.7 billion.
  • 02Curium purchased Lantheus in an $8 billion deal.
  • 03AstraZeneca's megamerger attempt was blocked.

Aug 3, 2026

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

CMS centralizes AI and interoperability under a new Office of Health Technology and Products

The Centers for Medicare & Medicaid Services (CMS) has established the Office of Health Technology and Products to integrate AI, interoperability, and digital strategies. This new office aims to enhance efficiency across Medicare, Medicaid, and CHIP programs. By centralizing these efforts, CMS seeks to improve healthcare delivery and outcomes.

  • 01The CMS has launched a new office focusing on AI and interoperability.
  • 02The Office of Health Technology and Products will support Medicare, Medicaid, and CHIP programs.
  • 03Centralizing digital strategies aims to improve healthcare delivery and outcomes.

Aug 1, 2026

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

CMS centralizes health tech authority in new office covering AI, interoperability, and claims modernization

The Centers for Medicare & Medicaid Services (CMS) has established a new Office of Health Technology and Products. This office assumes over 90 responsibilities to lead federal health IT strategy, focusing on areas like AI, interoperability, and claims modernization.

  • 01CMS's new office centralizes health tech authority, focusing on AI and interoperability.
  • 02The office takes on over 90 responsibilities to modernize claims processes.
  • 03CMS aims to lead federal health IT strategy with its new dedicated office.

Aug 1, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512